Nasopharyngeal Carcinoma Subtype Discovery via Immune Cell Scores from Tumor Microenvironment

BACKGROUND: Nasopharyngeal carcinoma (NPC) is one of the most prevalent cancers with a poor prognosis. Immunotherapy, especially immune checkpoint blockade (ICB), is becoming a potential therapeutic choice for NPC patients. Thus, the identification of patients who could benefit from immunotherapy is...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Yanbo, Liu, Yun, Chu, Hanqi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10234372/
https://www.ncbi.nlm.nih.gov/pubmed/37274867
http://dx.doi.org/10.1155/2023/2242577

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10234372/
https://www.ncbi.nlm.nih.gov/pubmed/37274867
http://dx.doi.org/10.1155/2023/2242577

Ejemplares similares